CCX-105

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCX-105
Drug Alias Namerheumatoid arthritis therapy (ChemoCentryx)multiple sclerosis therapy (ChemoCentryx)CCX-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A